0001140361-17-029083.txt : 20170728
0001140361-17-029083.hdr.sgml : 20170728
20170728150829
ACCESSION NUMBER: 0001140361-17-029083
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170726
FILED AS OF DATE: 20170728
DATE AS OF CHANGE: 20170728
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Greiner Michael
CENTRAL INDEX KEY: 0001520392
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50761
FILM NUMBER: 17989665
MAIL ADDRESS:
STREET 1: C/O VISTAPRINT
STREET 2: 95 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANGIODYNAMICS INC
CENTRAL INDEX KEY: 0001275187
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 113146460
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0531
BUSINESS ADDRESS:
STREET 1: 14 PLAZA DRIVE
CITY: LATHAM
STATE: NY
ZIP: 12110
BUSINESS PHONE: 5187981215
MAIL ADDRESS:
STREET 1: 14 PLAZA DRIVE
CITY: LATHAM
STATE: NY
ZIP: 12110
4
1
doc1.xml
FORM 4
X0306
4
2017-07-26
0
0001275187
ANGIODYNAMICS INC
ANGO
0001520392
Greiner Michael
14 PLAZA DRIVE
LATHAM
NY
12110
0
1
0
0
EVP and CFO
Common Stock
2017-07-26
4
A
0
6193
0
A
16193
D
Non-Qualified Stock Option (right to buy)
16.55
2017-07-26
4
A
0
21762
0
A
2018-07-26
2027-07-26
Common Stock
21762
21762
D
Performance Right
2017-07-26
4
A
0
12387
0
A
Common Stock
12387
12387
D
This acquisition of 6,193 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 6,193 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 26, 2018, such that 25% of the restricted stock units will vest on each of July 26, 2018, 2019, 2020 and 2021.
These stock options vest in four equal annual installments beginning on July 26, 2018, such that 25% of the options will vest on each of July 26, 2018, 2019, 2020 and 2021.
Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2020. Any shares that do not vest at the end of the performance period will be forfeited.
/s/ Stephen A. Trowbridge, Attorney in Fact
2017-07-28